Driving Better Decisions: Next-Generation Sequencing Insights for NSCLC Patients
Discover how Inspire’s research empowered lung cancer patients with actionable insights on NGS and clinical trial engagement.
Next-generation sequencing (NGS) plays a critical role in guiding treatment decisions for non-small cell lung cancer (NSCLC) patients, yet many remain unaware of its impact. Inspire’s case study, Empowering Lung Cancer Patients Through Next-Generation Sequencing Insights, highlights how Inspire’s research uncovered gaps in patient awareness and provided actionable insights to improve decision-making and clinical trial engagement.
In this case study, you’ll learn:
How Inspire’s surveys and interviews revealed that only 36% of patients knew they had undergone NGS, despite its importance in treatment planning.
The challenges patients face, including extended wait times for sequencing results and difficulties accessing clear clinical trial information.
How 50% of patients used mutation information to explore clinical trials, relying on media and patient organizations for guidance.
The need for better patient education and provider communication to reduce anxiety and improve outcomes.
Discover how Inspire’s insights can help empower NSCLC patients with the knowledge they need to make informed treatment decisions.